Skip to main content
Figure 2 | Journal of Experimental & Clinical Cancer Research

Figure 2

From: A pseudogene-signature in glioma predicts survival

Figure 2

Pseudogene risk score analysis of CGGA patients. The distribution of six-pseudogene risk score, patients’ survival status and pseudogene expression signature were analyzed in the entire CGGA patients (n = 183). The vertical axis in (A) means risk score. The vertical axis in (B) means survival time (days). The dotted line in the middle divided the patients into two groups – one group with low risk score and the other one with high score. As the risk score rising, the patients had a shorter survival time. As the risk score rising, the expression value of TDH lowered, and the other 5 pseudogenes’ ascended, which meant the TDH was a protective one, and the other 5 were risky. (A) Pseudogenes risk score distribution; (B) Patients’ survival status and time; (C) Heatmap of the pseudogene expression profiles. Rows represent pseudogenes, and columns represent patients. The black dotted line represents the median pseudogenes risk score cutoff dividing patients into low-risk and high-risk groups.

Back to article page